12.1 Neonatal Glucose, Electrolyte, Endocrine & Metabolic Disorders
Key Takeaways
- Screen symptomatic newborns immediately and routinely screen established risk groups such as SGA, LGA, infants of diabetic mothers, and late-preterm infants.
- AAP transitional operational thresholds guide action: refeed/recheck asymptomatic at-risk infants below 25 mg/dL at 0–4 hours or below 35 mg/dL at 4–24 hours; persistent low values require IV treatment.
- Symptomatic hypoglycemia needs immediate laboratory confirmation without delaying treatment; IV dextrose is appropriate for severe, symptomatic, or feeding/gel-refractory hypoglycemia.
- PES targets for persistent/recurrent disease are not interchangeable with AAP operational thresholds for routine transitional screening.
- Recurrent hypoglycemia, acidosis, hyperammonemia, unusual odor, or deterioration after a symptom-free interval suggests endocrine or inborn metabolic disease and requires urgent specialist evaluation.
12.1 Neonatal Glucose, Electrolyte, Endocrine & Metabolic Disorders
Core Focus: A glucose number must be interpreted by age, symptoms, risk, feeding, and whether the problem is transitional or persistent. Stabilize symptomatic infants and recognize when recurrent abnormalities signal endocrine or genetic metabolic disease.
Risk and screening
Screen immediately for jitteriness, tremor, lethargy, poor feeding, hypotonia, apnea, cyanosis, temperature instability, weak/high-pitched cry, or seizure. Routine risk groups include small- or large-for-gestational-age infants, infants of diabetic mothers (IDM), and late-preterm infants. Other indications include significant illness, hypoxia, hypothermia, or medications that affect glucose.
Feed an asymptomatic at-risk newborn early and screen according to age and policy. Bedside meters are least accurate at low concentrations; obtain a laboratory plasma glucose when the result will determine major treatment, but do not delay treatment of a symptomatic or severely low infant.
AAP operational thresholds during transition
For an asymptomatic at-risk infant:
- Birth to 4 hours: if glucose is below 25 mg/dL, feed (and use 40% buccal dextrose gel when included in protocol), then recheck in about one hour. Persistent value below 25 requires IV glucose.
- 4 to 24 hours: if below 35 mg/dL, feed/gel and recheck; persistent value below 35 requires IV glucose.
- Continue monitoring until the infant maintains the protocol target through feed–fast cycles. After 24 hours, inability to maintain values above about 45 mg/dL requires continued evaluation.
A symptomatic infant with glucose below 40 mg/dL generally needs immediate IV treatment. Protocols commonly use 10% dextrose 2 mL/kg (200 mg/kg) followed by a glucose infusion, with frequent rechecks. Avoid concentrated peripheral dextrose that injures veins.
Forty-percent dextrose gel is commonly 0.5 mL/kg (200 mg/kg) massaged into the buccal mucosa, followed by feeding and a protocol-timed recheck. It is not squirted into the posterior pharynx and does not replace IV therapy for severe symptoms or failed enteral treatment.
The Pediatric Endocrine Society uses higher treatment targets when persistent/recurrent hypoglycemia is suspected—often >50 mg/dL during the first 48 hours and >60 mg/dL thereafter. Those goals address possible pathologic disease and should not be mislabeled as the AAP's screening thresholds for normal transition.
Infants of diabetic mothers
Maternal hyperglycemia drives fetal hyperinsulinemia. After cord clamping, glucose supply stops while insulin remains high, so the nadir often occurs early. IDM complications also include polycythemia, hypocalcemia, respiratory distress, hypertrophic cardiomyopathy, hyperbilirubinemia, and birth injury when large for gestational age. Feed early, screen glucose on schedule, and assess respiratory, cardiac, hematologic, and calcium-related findings.
Persistent hypoglycemia and critical samples
Concern rises when glucose cannot be maintained despite adequate intake/infusion, requires an unusually high glucose infusion rate, or persists beyond expected transition. Under specialist direction, collect a critical sample during hypoglycemia—glucose, beta-hydroxybutyrate, free fatty acids, insulin/C-peptide, cortisol, growth hormone, lactate, ammonia, acylcarnitine profile, and urine organic acids as appropriate—without delaying stabilization. Hyperinsulinism often produces low ketones and free fatty acids despite low glucose.
Hypocalcemia
Risk is higher with prematurity, IDM status, perinatal stress, maternal hyperparathyroidism, or high phosphate load. Findings overlap with hypoglycemia: jitteriness, poor feeding, apnea, laryngospasm, prolonged QT, or seizure. Measure ionized calcium when possible. Symptomatic significant hypocalcemia may require slow IV calcium gluconate with continuous heart-rate/ECG monitoring and a secure venous line; stop for bradycardia or extravasation. Never give calcium through an umbilical arterial catheter or mix it with bicarbonate in the same line.
Inborn errors, inheritance, and endocrine clues
An infant with a symptom-free interval followed by poor feeding, vomiting, lethargy, tachypnea, seizures, acidosis, hypoglycemia, hyperammonemia, liver dysfunction, or an unusual odor may have an inborn error of metabolism. Stop unsafe protein/galactose/fructose exposure only under the emergency metabolic plan, stabilize glucose and perfusion, collect critical specimens if feasible, and contact a metabolic specialist immediately. A newborn screen is a screen, not proof that symptomatic disease is absent.
Many inborn errors are autosomal recessive, so unaffected parents may have an affected child and recurrence risk can be substantial. G6PD deficiency is X-linked and can cause hemolysis after oxidative stress. Family history, consanguinity, previous unexplained neonatal death, ethnicity/ancestry when clinically relevant, and prenatal findings inform evaluation without replacing testing.
Hyperglycemia and other endocrine emergencies
Hyperglycemia is most common in very preterm or critically ill infants receiving glucose infusion, steroids, catecholamines, or inadequate insulin response. Confirm a high bedside value, review the glucose infusion rate and medications, assess hydration/osmotic diuresis, and treat the underlying stressor. Do not abruptly eliminate needed calories or give insulin without a closely monitored neonatal protocol because rapid shifts can cause hypoglycemia and electrolyte changes.
Congenital adrenal hyperplasia can present after a symptom-free interval with vomiting, weight loss, dehydration, hyponatremia, hyperkalemia, hypoglycemia, and shock; genital appearance varies and does not exclude it. Obtain emergency electrolytes/glucose and endocrine evaluation and begin stress-dose treatment and fluid resuscitation as ordered. Hypothyroidism is usually detected by newborn screening before symptoms; prompt confirmatory testing and levothyroxine protect neurodevelopment. These examples reinforce that screening follow-up is part of treatment and that a sick infant is evaluated before a screening result returns.
A 38-week male infant weighing 4,350 g is delivered to a mother with poorly controlled gestational diabetes. At 90 minutes of life, the infant exhibits fine tremors of both upper extremities while resting in the crib. When the nurse gently grasps and flexes the infant's arms, the tremors immediately cease. The infant's vital signs are normal, and ocular movements are calm and centered. Which pathophysiological rationale and immediate nursing action are indicated?
An asymptomatic late-preterm infant has glucose 32 mg/dL at 2 hours of life after an early feed. Which action fits an AAP-based protocol that includes dextrose gel?
A 3-day-old infant delivered after severe intrapartum asphyxia exhibits persistent muscle twitching, high-pitched crying, and an electrocardiogram demonstrating a QTc interval of 0.46 seconds. Total serum calcium is 6.4 mg/dL. The practitioner orders 10% calcium gluconate 100 mg/kg IV. Which nursing precaution is critical during the infusion of this medication?